| 经血源性子宫内膜间充质干细胞的分离、培养与鉴定***** |
| |
| 引用本文： | 周云帆,杨 波,胡 祥,焦洪亮,周长辉,田 毅,雷宁静,谷晨熙,许予明,戴建武,关方霞.经血源性子宫内膜间充质干细胞的分离、培养与鉴定*****[J].中国神经再生研究,2010,14(32):5952-5956. |
| |
| 作者姓名： | 周云帆 杨 波 胡 祥 焦洪亮 周长辉 田 毅 雷宁静 谷晨熙 许予明 戴建武 关方霞 |
| |
| 作者单位： | 郑州大学生物工程系，河南省郑州市 450001:河南省高等学校临床医学重点学科开放实验室，河南省郑州市450052,河南省高等学校临床医学重点学科开放实验室，河南省郑州市450052;郑州大学第一附属医院神经外科，河南省郑州市 450052,江苏省干细胞与生物治疗公共技术服务平台，江苏省泰州市 225300;深圳市北科细胞工程研究所，广东省深圳市 518000,河南省高等学校临床医学重点学科开放实验室，河南省郑州市450052;郑州大学第一附属医院神经外科，河南省郑州市 450052,郑州大学生物工程系，河南省郑州市 450001,河南省高等学校临床医学重点学科开放实验室，河南省郑州市450052;郑州大学第一附属医院神经外科，河南省郑州市 450052,郑州大学生物工程系，河南省郑州市 450001,郑州大学临床医学系，河南省郑州市 450001,郑州大学第一附属医院神经内科，河南省郑州市 450052,中国科学院遗传与发育生物学研究所，北京市 100190,郑州大学生物工程系，河南省郑州市 450001 |
| |
| 基金项目： | 郑州大学211三期建设项目“干细胞基础与临床研究；河南省科技厅2009科技发展计划项目(092102310250)；河南省青年骨干教师资助项目；郑州市二七区科技攻关计划项目(20095157)；江苏省干细胞与生物治疗公共技术服务平台项目(BM2008146) |
| |
| 摘 要： | 背景：目前用于干细胞研究的主要来源为胚胎干细胞和骨髓干细胞，但这两种来源都存在着部分局限性，因此需要寻找一种新型的干细胞以克服肿瘤形成的潜在性、标本来源的缺乏及伦理学的争议等弊端。
目的：分离培养经血源性子宫内膜间充质干细胞并进行鉴定。
方法：采用Ficoll密度梯度离心法分离出人经血源性子宫内膜间充质干细胞，对细胞的形态及生长特性进行观察；采用流式细胞仪对细胞表面抗原CD29、CD44、CD34 、CD45、HLA-ABC及HLA-DR进行表型鉴定；免疫细胞化学法测定经血源性子宫内膜间充质干细胞中nestin阳性细胞表达。
结果与结论：应用Ficoll密度梯度离心法可以从女性月经血中分离培养出干细胞，约2周原代细胞达到80%~90%融合，细胞呈漩涡状、网状、辐射状。传代后能稳定生长，可见纤维样细胞形态为主导。流式检测结果显示，经血源性子宫内膜间充质干细胞表现出CD29强阳性，CD44阳性，CD34 、CD45 、HLA-DR阴性，低表达HLA-ABC。染色显示nestin抗原在经血源性子宫内膜间充质干细胞中有表达，约占经血源性子宫内膜间充质干细胞的(10.35±0.51) %。结果表明经血源性子宫内膜间充质干细胞表达间充质干细胞的标记物，具低免疫源性；经血源性子宫内膜间充质干细胞表达nestin抗原，为经血源性子宫内膜间充质干细胞在神经系统应用提供一定的理论依据。
|
| 关 键 词： | 经血 子宫内膜 间充质干细胞 表型鉴定 巢蛋白 |
Isolation, culture and identification of menstrual blood-derived mesenchymal stem cells |
| |
| Zhou Yun-fan,Yang Bo,Hu Xiang,Jiao Hong-liang,Zhou Chang-hui,Tian Yi,Lei Ning-jing,Gu Chen-xi,Xu Yu-ming,Dai Jian-wu and Guan Fang-xia.Isolation, culture and identification of menstrual blood-derived mesenchymal stem cells[J].Neural Regeneration Research,2010,14(32):5952-5956. |
| |
| Authors: | Zhou Yun-fan Yang Bo Hu Xiang Jiao Hong-liang Zhou Chang-hui Tian Yi Lei Ning-jing Gu Chen-xi Xu Yu-ming Dai Jian-wu and Guan Fang-xia |
| |
| Institution: | Department of Bioengineering, Zhengzhou University, Zhengzhou 450001, Henan Province, China;Open Laboratory of Clinical Medicine and Key Subject, Henan Institution of Higher Education, Zhengzhou 450052, Henan Province, China,Open Laboratory of Clinical Medicine and Key Subject, Henan Institution of Higher Education, Zhengzhou 450052, Henan Province, China;Department of Neurosurgery, First Affiliated Hospital, Zhengzhou University, Zhengzhou 450052, Henan Province, China,Jiangsu Public Technology Service Platform of Stem Cells and Biotherapy, Taizhou 225300, Jiangsu Province, China;Shenzhen Beike Cell Engineering Institute, Shenzhen 518000, Guangdong Province, China,Open Laboratory of Clinical Medicine and Key Subject, Henan Institution of Higher Education, Zhengzhou 450052, Henan Province, China;Department of Neurosurgery, First Affiliated Hospital, Zhengzhou University, Zhengzhou 450052, Henan Province, China,Department of Bioengineering, Zhengzhou University, Zhengzhou 450001, Henan Province, China,Open Laboratory of Clinical Medicine and Key Subject, Henan Institution of Higher Education, Zhengzhou 450052, Henan Province, China;Department of Neurosurgery, First Affiliated Hospital, Zhengzhou University, Zhengzhou 450052, Henan Province, China,Department of Bioengineering, Zhengzhou University, Zhengzhou 450001, Henan Province, China,Department of Clinical Medicine, Zhengzhou University, Zhengzhou 450001, Henan Province, China,Department of Neurology, First Affiliated Hospital, Zhengzhou University, Zhengzhou 450052, Henan Province, China,Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing 100190, China,Department of Bioengineering, Zhengzhou University, Zhengzhou 450001, Henan Province, China |
| |
| Abstract: | BACKGROUND: Generally, the main sources of stem cells are embryonic stem cells and bone marrow stem cells, but there are some limitations of the two kinds of sources, and researchers strive to find a new type of stem cells in order to overcome the potential for teratoma, the lack of sample sources, ethics controversies and so on.
OBJECTIVE: To isolate, culture and identify menstrual blood-derived mesenchymal stem cells (MMCs).
METHODS: MMCs were separated by Ficoll density gradient centrifugation. Cell morphology and growth characteristics were observed. Flow cytometry analysis was used to identify expression of CD29, CD44, CD34, CD45, HLA-ABC and HLA-DR surface markers in MMCs. Immunocytochemical method was utilized to detect nestin-positive cells in MMCs.
RESULTS AND CONCLUSION: MMCs were successfully separated from menstrual blood by Ficoll density gradient centrifugation. About 2 weeks later, primary cells reached 80% to 90% confluence; cells were spiral-shaped, mesh and radial. After passage to a stable growth, cells could be seen as the leading fiber-like cell morphology. Results from flow cytometry showed that MMCs were highly positive for CD29, positive for CD44, low positive for HLA-ABC, but negative for CD34, CD45 and HLA-DR. Staining showed nestin expression of antigen in MMCs was about (10.35±0.51)%. Results have suggested that MMCs express MSCs markers, and only have low immunogenicity. MMCs express nestin antigen and provide some theoretical basis for MMCs in the nervous system application. |
| |
| Keywords: | |
|
| 点击此处可从《中国神经再生研究》浏览原始摘要信息 |
| 点击此处可从《中国神经再生研究》下载免费的PDF全文 |
|
